Syndax Pharmaceuticals · 3 days ago
Senior Financial Analyst
Wonder how qualified you are to the job?
Maximize your interview chances
BiotechnologyClinical Trials
Insider Connection @Syndax Pharmaceuticals
Responsibilities
Provide increased support in Monthly Accrual Process
Ensure all POs are properly accrued and provide supporting documentation for material accruals
Support transition to automated accrual platform
Research accounting discrepancies vs. budget
Support PO change process and align with accrual estimates
Enhanced monthly reporting – Actual vs. Budget
Lead reporting at PO level to provide additional insight into actual operating results
Ensure expenses are correctly recorded in P&L – provide adjusting journal entries as required
Support Budgeting / Forecast process
Support FP&A team with Annual and Quarterly Forecast
Help develop supporting documentation for material spend
Manage budget load process
Support increase in FP&A support for Commercial
Support GTN actuals and forecast – aligning with Commercial non-financial data
Support Co-promotion collaboration with timely and accurate financial reporting
Increase reporting including key non-financial data (Units Shipped, Patient Starts, TRx, Co-pay assistance)
Support COGS Analysis - Gross Profit Analysis
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Bachelor’s degree and 3+ years of FP&A experience in a business partnering capacity
Knowledge of accounting and finance concepts and working knowledge of US GAAP is required
Excellent written and oral communication skills
Demonstrated strong analytical skills and demonstrated ability to balance strategic thinking with bottoms-up detailed analysis
Strong Excel skills and hands-on experience with financial analytics and modeling
Strong knowledge of systems and tools for managing a financial forecast
Strong experience in budgeting and forecasting including exposure to planning and reporting
Ability to manage multiple priorities simultaneously
Preferred
Pharmaceuticals or biotech experience preferred; prior experience in drug development activities in biopharma or healthcare industry, including commercial operations in the U.S. and worldwide markets, is preferred
Company
Syndax Pharmaceuticals
Syndax Pharmaceuticals focuses on developing an HDAC inhibitor for solid tumors and hematological tumors.
Funding
Current Stage
Public CompanyTotal Funding
$803.58M2023-12-14Post Ipo Equity· $230M
2022-12-06Post Ipo Equity· $150M
2021-12-15Post Ipo Equity· $75.3M
Leadership Team
Recent News
Investor's Business Daily
2024-06-05
Company data provided by crunchbase